Comparing Lanreotide vs Somatuline Depot
Lanreotide |
Somatuline Depotlanreotide |
||||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescribed for Neuroendocrine Carcinoma, Carcinoid Syndrome, Acromegaly. lanreotide may also be used for purposes not listed in this medication guide. |
Prescribed for Neuroendocrine Carcinoma, Carcinoid Syndrome, Acromegaly. Somatuline Depot may also be used for purposes not listed in this medication guide. |
Choose a suggestion belowAcromegaly
Neuroendocrine Carcinoma
Carcinoid Syndrome
|
|||||||
|
Prescription only |
Prescription only |
||||||||
Ratings & ReviewsRecent helpful reviews |
|||||||||
|
N/A |
N/A |
||||||||
Drug Class |
|||||||||
Side Effects |
|||||||||
|
Commonly reported side effects include: diarrhea. See the full lanreotide side effects document. |
Common side effects include: diarrhea. See the full Somatuline Depot side effects document. |
||||||||
Pricing and Coupons* Prices are without insurance |
|||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
||||||||
Generic Availability |
|||||||||
|
No |
No |
||||||||
Dosage Form(s) Available |
|||||||||
| N/A |
|
||||||||
Brand Names |
|||||||||
| Somatuline Depot |
N/A |
||||||||
Half LifeThe half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. |
|||||||||
|
720 hours |
720 hours |
||||||||
CSA Schedule**View glossary of terms. |
|||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category |
|||||||||
|
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
||||||||
FDA Alerts |
|||||||||
|
N/A |
N/A |
||||||||
Drug Interactions |
|||||||||
|
A total of 172 drugs are known to interact with lanreotide:
|
A total of 172 drugs are known to interact with Somatuline Depot:
|
||||||||
Alcohol/Food/Lifestyle Interactions |
|||||||||
|
|
||||||||
Disease Interactions |
|||||||||
First Approval Date |
|||||||||
|
August 30, 2007 |
N/A |
||||||||
WADA ClassView World Anti-Doping Agency classifications. |
|||||||||
|
N/A |
N/A |
||||||||
More Information |
|||||||||
Consumer Resources |
|||||||||
Professional Resources |
|||||||||
Related Treatment Guide |
|||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
